Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

October 9, 2023

Study Completion Date

October 9, 2023

Conditions
End Stage Renal Disease on Hemodialysis
Interventions
DRUG

Difelikefalin Injection

Participants receive Difelikefalin three times a week (0,5 micrograms/kg dry body weight). Difelikefalin is administered by intravenous bolus injection into the venous line of the dialysis circuit at the end of each dialysis.

Trial Locations (4)

Unknown

Investigator Site 1, Beijing

Investigator Site 2, Beijing

Investigator Site 3, Beijing

Investigator Site 4, Shijiazhuang

All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Vifor Fresenius Medical Care Renal Pharma

INDUSTRY

NCT05885763 - Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis | Biotech Hunter | Biotech Hunter